Sunday - November 15, 2026
Washington University St. Louis George Warren Brown School: Study Links GLP-1 Drugs to Lower Heart Risks in People With Serious Mental Illness
October 28, 2026
ST. LOUIS, Missouri, Oct. 28 (TNSjou) -- The Washington University St. Louis George Warren Brown School issued the following news:

* * *

Study links GLP-1 drugs to lower heart risks in people with serious mental illness

Myra Lopez

10/27/2026

GLP-1 medications, including semaglutide and tirzepatide, are associated with lower risks of heart attack, heart failure and death among adults with serious mental illness, Type 2 diabetes and . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Click here for more information about our products